Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold?

Overview of attention for article published in Blood Reviews, December 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 1 news outlet

twitter: 24 X users

Readers on

mendeley: 31 Mendeley

So far, Altmetric has seen 25 X posts from 24 X users, with an upper bound of 72,257 followers.

RT @smbenlazar: Acute myeloid leukemia resistant to venetoclax-based therapy: What does the future hold? https://t.co/zOtvKKPNIy #AML #leus…

Acute myeloid leukemia resistant to venetoclax-based therapy: What doe... https://t.co/0ETlqswB5t

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 21 additional X posts.